Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 1, Pages 1051-1065
Publisher
MDPI AG
Online
2015-01-05
DOI
10.3390/ijms16011051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer
- (2017) Katarina Sebova et al. Cancer Biomarkers
- Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
- (2014) Jian-Guo Ma MEDICAL SCIENCE MONITOR
- Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression
- (2013) Wei He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aberrant promoter hypermethylation ofPBRM1,BAP1,SETD2,KDM6Aand other chromatin-modifying genes is absent or rare in clear cell RCC
- (2013) Ilsiya Ibragimova et al. Epigenetics
- Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
- (2013) Christopher J Ricketts et al. Clinical Epigenetics
- GATA5CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression
- (2012) Inga Peters et al. BJU INTERNATIONAL
- Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma
- (2012) Christopher J. Ricketts et al. Epigenetics
- Epigenetic disruption of cadherin-11 in human cancer metastasis
- (2012) F. Javier Carmona et al. JOURNAL OF PATHOLOGY
- Establishment of diagnosis by bisulfite-treated methylation-specific PCR method and analysis of clinical characteristics of pseudohypoparathyroidism type 1b
- (2011) Kaori Kinoshita et al. ENDOCRINE JOURNAL
- Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma
- (2011) Masayoshi Nagata et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic Silencing of a Proapoptotic Cell Adhesion Molecule, the Immunoglobulin Superfamily Member IGSF4, by Promoter CpG Methylation Protects Hodgkin Lymphoma Cells from Apoptosis
- (2010) Paul G. Murray et al. AMERICAN JOURNAL OF PATHOLOGY
- Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage
- (2010) Qian Zhang et al. JOURNAL OF UROLOGY
- Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens
- (2010) Remco M. van den Berg et al. LUNG CANCER
- Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma
- (2010) M R Morris et al. ONCOGENE
- Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
- (2010) M R Morris et al. ONCOGENE
- Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
- (2010) Mark R Morris et al. Genome Medicine
- High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers
- (2009) Zhi Li et al. MEDICAL ONCOLOGY
- Multigene Methylation Analysis of Conventional Renal Cell Carcinoma
- (2009) H. Onay et al. UROLOGIA INTERNATIONALIS
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started